2019 Endowment Fund Grants: successful grant recipients

Twenty-two new ground-breaking Peter Mac cancer research projects will be established thanks to the generosity of donors to the Foundation’s Perpetual Endowment Fund. In total, $1.1m in seed funding was awarded through the Foundation's 2019 Endowment Fund Grants program to help kick-start some of Peter Mac's most exciting new cancer research initiatives. 

Our most grateful thanks go to the generous individuals who have enabled these annual Grants by donating to the Foundation's Endowment Fund.

Recipients of this year's Grants are:


Project Title


Alexander, Marliese

Australian registry for ROS1 rearranged non-small cell lung cancer - a framework for prospective collection of clinical data and consent to access biospecimens.

Cancer Medicine

Atkin, Nicola

An open-label, single-arm feasibility study of oral lorazepam for symptoms of anxiety in patients with advanced cancer.

Chief Medical Officer

Brennan, Amelia

Overcoming tumour cell resistance to natural immunity and immunotherapy.


Burdett, Nikki

Emquest-Identifying factors which predict for health-related quality of life deficits and increased symptom burden in women who have been treated for endometrial cancer.

Medical Oncology

Christie, Liz

Understanding spatial patterning of resistance in ovarian cancer.

Cancer Research

Clemons, Nicholas

Multiplexed single-cell CRISPR activation and knockout tumourigenesis screen to establish functional genetic drivers of oesophageal adenocarcinoma.

Cancer Research

Haskali, Mohammad

Development of Ga-68/Lu-177 labelled Carfilzomib for the diagnosis and therapy of Multiple Myeloma.

Radiation Oncology

Hoskins, Cass

Young people's experiences of managing significantly increased risk of gastric cancer due to a CDH1 mutation.

Parkville Familial Cancer Centre

Joyce, Trish

Precision preparation: Working with haematology patients and family carers to safely deliver outpatient complex cancer therapies.


Lai, Junyun

Using new generation CRISPR/Cas9-mediated genomic engineering to enhance CAR T-cell efficacy in solid cancers.

Cancer Research

Lewin, Jeremy

RNAseq-based assay for diagnosis and clinical management of sarcoma.

ONTrac at Peter Mac Victorian Adolescent & Young Adult Cancer Service

Liddicoat, Brian

Understanding the clonal evolution and maintenance of CAR T-cell persistence.

Cancer Epigenetics

Lonski, Peta

3-dimensional modelling of radiation doses to the lungs of patients undergoing total body irradiation treatment for haematological malignancies.

Radiation Oncology

Lupat, Richard

Powering Personalised Medicine through FPGA-based Ultra-Rapid Secondary Analysis of NGS Data.

Cancer Research

McDonald, Geraldine

Supporting staff to deliver better EoL care.

Chief Medical Officer

Pereira, Lloyd

A tumouroid based preclinical model for Adenoid Cystic Carcinoma of the Salivary Gland.

Cancer Research

Ryland, Georgina

Identifying Ph-like B-acute lymphoblastic leukaemia - a poor risk subtype with the potential for targeted therapy.

Centre for Clinical Cancer Genomics

Smith, Cassandra

Improving consumer engagement in cancer research: Identifying and minimising the barriers for consumers to partner with researchers.


Vassiliadis, Dane

Single-cell analysis of non-genomic cancer cell adaptation to therapeutic intervention.

Cancer Research

Vervoort, Stephin

Feature-seq: Simultaneous single cell RNA-sequencing and surface protein expression profiling on pooled mouse or patient tumour filtrating T-cell samples.

Research (Translational Haematology)

Voskoboinik, Ilia

Understanding cancer cell resistance to cytotoxic lymphocytes and immunotherapy.


Yong, Michelle

Biomarker predictors for respiratory viral and fungal infections in malignant haematology and haematopoietic stem cell transplant recipients.

Chief Medical Officer

To view the 2018 Peter Mac cancer research projects that were established through the Foundation's Endowment Fund click here.